共 168 条
[1]
Tarantini L(2012)Trastuzumab adjuvant chemotherapy and cardiotoxicity in real-world women with breast cancer J Card Fail 18 113-119
[2]
Cioffi G(2012)Incidence of heart failure or cardiomyopathy after adjuvant Trastuzumab therapy for breast Cancer J Am Coll Cardiol 60 2504-2512
[3]
Gori S(2017)A population-based study of cardiovascular mortality following early-stage breast cancer JAMA Cardiol 2 88-93
[4]
Tuccia F(2017)Risk of death from cardiovascular disease following breast cancer: a systematic review Breast Cancer Res Treat 164 537-555
[5]
Boccardi L(2016)Cardiovascular disease mortality among breast Cancer survivors Epidemiology. 27 6-13
[6]
Bovelli D(2003)Congestive heart failure in patients treated with doxorubicin: a retrospective analysis of three trials Cancer. 97 2869-2879
[7]
Lestuzzi C(2014)Longitudinal assessment of concurrent changes in left ventricular ejection fraction and left ventricular myocardial tissue characteristics after administration of cardiotoxic chemotherapies using T1-weighted and T2-weighted cardiovascular magnetic resonance Circ Cardiovasc Imaging 7 872-879
[8]
Maurea N(2013)Long-term cardiovascular toxicity in children, adolescents, and young adults who receive cancer therapy: pathophysiology, course, monitoring, management, prevention, and research directions: a scientific statement from the American Heart Association Circulation. 128 1927-1995
[9]
Oliva S(2005)Chronic progressive cardiac dysfunction years after doxorubicin therapy for childhood acute lymphoblastic leukemia J Clin Oncol 23 2629-2636
[10]
Russo G(2009)Neuregulin-1beta is associated with disease severity and adverse outcomes in chronic heart failure Circulation 120 310-317